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The world is facing a growing diabetes mellitus (DM) epi-
demic, and diabetic foot ulcers, with an estimated lifetime risk 
of 25%,40 constitute one of the most common complications of 
this disease. About 58% of ulcers become clinically infected,32 of-
ten leading to amputation. Diabetic wounds6,13 do not follow the 
precisely orchestrated course of events observed in normal heal-
ing, and bacterial colonization or infection further disrupts this 
process.14 In current clinical practice, once an adequate blood sup-
ply is assured, the treatment of diabetic foot infections includes 
debridement, systemic antibiotics, and dressings.24 Mechanical 
debridement is pivotal to this strategy, because it not only sig-
nificantly reduces the bioburden but also opens a time-dependent 
therapeutic window for topical antimicrobial therapy (TAT).50 
TAT agents consist of an active antimicrobial molecule associated 
with a vehicle or base, thereby delivering a high and sustained 
antibiotic concentration directly to the site of infection while 
avoiding systemic toxicity.25
Several new TAT agents are under investigation, and a phased 
strategy of efficacy and toxicity testing is required before they 
can be made widely available for human use. None of the pres-
ently available in vitro or in vivo models of wound healing is 
optimal. As experimental models, in vitro tests fail to reproduce 
the physiologic and pathogenic complexity of an organism, mak-
ing in vivo models a crucial tool for ensuring clinical relevance.36 
Researchers have studied in vivo wound healing in a variety of 
species, including pigs,48 rabbits,1 rats,12,35,46 and mice,6,47 by using 
different incisional, excisional, and granulation wound models in 
animals rendered diabetic through genetic modification or chemi-
cal induction.
For most researchers, rodents are the model of choice because 
they are inexpensive, easy to handle, require little space, and have 
accelerated healing compared with humans, thereby yielding for 
faster results.36 The excisional wound model accommodates the 
broadest assessment of the mechanisms involved in wound heal-
ing, including epithelialization, granulation, and angiogenesis.51 
In addition, this model supports the evaluation of new topical 
pharmacologic interventions because medications can be applied 
directly to the wound bed.46,47 All models of excisional wound 
healing are based on the same principles (Figure 1).36 However, 
these models have been criticized because the main mechanism 
of wound healing in rodents is contraction16 due to the presence 
of the panniculus carnosus muscle in the subcutaneous tissue; in 
contrast, humans heal more through reepithelialization.14 One 
rodent excisional wound healing model minimizes wound con-
traction by the use of silicone splints that are fixed to the skin 
by using immediate-bonding adhesive and nylon sutures. 16 Al-
though potentially useful for evaluating diabetic wound bacte-
rial infections, this model has not been tested or validated in this 
context. Other published animal models of infected cutaneous 
wounds39,54 fail to afford the optimal characteristics of the model 
cited previously.16 Still, this model16 is not without disadvantages, 
namely the difficulty of applying and maintaining the dressing 
(and splint) while maintaining stringent infection control.
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buffer (pH 4.5). At 8 d after streptozotocin injection, blood glucose 
measurement was performed on tail-vein blood by using a glu-
cometer (Accu-Chek Aviva Nano, Roche Diagnostics, Penzberg, 
Germany). Rats whose fasting blood glucose levels exceeded 250 
mg/dL (13.9 mmol/dL) were considered diabetic. Water intake 
and weight were monitor throughout the study, and to confirm 
the diabetic state, fasting blood glucose measurement was re-
peated on the day of euthanasia.
Optimization study 1: hair removal. On the day of DM con-
firmation, 9 diabetic rats were anesthetized by intraperitoneal 
injection of xylazine hydrochloride (10 mg/kg) and ketamine 
hydrochloride (25 mg/kg), and their dorsal surface hair was 
trimmed with an electric clipper. Rats then were divided into 3 
groups depending on the method used to remove any remaining 
hair: straight razor; 2) depilatory cream (Opilca, GlaxoSmithKline 
Consumer Healthcare, Copenhagen, Denmark); and 3) cold wax 
(Veet cold wax strips, Reckitt Benckiser, West Ryde, Australia). 
The dorsum of all rats was rinsed with a 10% povidone–iodine 
solution and, after drying and cleansing, a liquid film-forming 
acrylate (Cavilon Skin Cleanser, 3M Health Care, Saint Paul, MN) 
was applied evenly to cover the hair removal area. A photograph 
of the dorsum of the rat was taken from a 1.5 cm standard height 
(ES65 digital camera, Samsung, Beijing, China), and the rats were 
placed on a 37 °C heating pad to minimize hypothermia. All rats 
received sterile sodium chloride to prevent dehydration. After 
fully recovering from anesthesia, rats were placed in individual 
cages. Photographs of nonanesthetized rats were taken on days 
4 and 14 after hair removal and used by 3 independent observ-
ers for evaluation of the hair-density index (scale: 1 [no hair] to 5 
[normal amount of hair]) and skin-damage index (scale: 1, intact 
skin; 2, erythematous skin; 3, epidermal injury; 4, dermal injury; 
and 5, subcutaneous layer injury). Hair density and skin damage 
scores are expressed as the median (first and third quartiles).
Optimization study 2: prevention of unintentional critical col-
onization. Based on the findings of the previous optimization 
study, 18 Wistar rats with chemically induced DM were epilated 
by using cold wax and anesthetized by intraperitoneal injection of 
xylazine–ketamine 4 d thereafter.
Because, to our knowledge, better in vivo models are not avail-
able for the evaluation of TAT in diabetic wound infections, we 
refined and adapted the previous murine model16 to develop a 
useful and cost-effective model for this purpose.
Materials and Methods
This study was approved locally by the Animal Ethics Commit-
tee of the Instituto de Medicina Molecular and nationally by the 
Portuguese General Directorate of Veterinary Services (Direcção 
Geral de Veterinária), in accordance with Portuguese law. All 
animals were maintained in accordance with European Directive 
86/609/EC,10 Portuguese law (Portaria 1005/92),31 and the Guide 
for the Care and Use of Laboratory Animals.21 This study included 
the refinement and optimization of several sequential procedures. 
The animals used and the DM induction protocol were the same 
for all study groups. The final optimized wound-infection model 
study was preceded by 3 sequential optimization studies: hair 
removal (optimization study 1); prevention of unintentional criti-
cal colonization (optimization study 2); and assessment of wound 
bioburden (optimization study 3). To reduce the number of study 
groups, and therefore the total number of animals, each subse-
quent optimization study incorporated the findings of previous 
studies.
Animals. Specific pathogen-free male Wistar rats (Crl:WI[Han]; 
weight, 250 to 350 g; age, 8 to 10 wk) were obtained from Charles 
River Laboratories (L’ Arbresle Cedex, France) and kept in an 
approved animal care center. The rats were maintained in microi-
solation caging in a room with controlled humidity (50% to 70%) 
and temperature (20 to 22 °C), a 14:10-h light:dark cycle, and free 
access to pelleted rodent chow (RM3, Special Diet Systems, Essex, 
UK) and filter-sterilized water. Initially housed in groups of 2, rats 
were housed individually after hair removal to preserve skin and 
dressing integrity.
Induction of DM. DM was induced chemically as described 
previously.52 Briefly, after a 12-h fast, rats received a single intrap-
eritoneal injection of streptozotocin (65 mg/kg; Merck Chemical, 
Darmstadt, Germany) freshly prepared in 0.1 M sodium citrate 
Figure 1. Schematic representation of diabetic rodent models of excisional wound healing. (1) Genetically modified or chemically induced diabetic ani-
mals are used. (2) Hair is removed (various techniques are available). (3) A full-thickness wound extending through the panniculus carnosus is created 
in the interscapular region of the upper back, typically by using a punch biopsy instrument. (4) Some models use a silicone splint fixed to the skin, for 
minimizing wound contraction while allowing the normal granulation and reepithelialization. (5) The wound is covered with a semiocclusive dressing. 
Various macroscopic and microscopic methods are available for the evaluation of wound closure.
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ness round wound extending through the panniculus carnosus 
in the interscapular region of the upper back of each rat, and the 
skin flap was excised by using iris scissors. An oval-shaped sili-
cone splint (Figure 2 A) was adapted from a self-adhesive corn 
cushion (Comforsil, Toledo, Spain). Immediate-bonding cyanoac-
rylate glue in a disposable single-dose package (Loctite, Henkel 
Corporation, Westlake, OH) was used to fix the splint to the skin, 
followed by interrupted 3-0 nylon sutures to ensure its position. 
Liquid film-forming acrylate was applied to the epilated area, and 
the wound and surrounding area were covered with a previously 
tailored, semiocclusive, nonwoven polyester dressing (Fixomull 
Stretch, BSN Medical, Hamburg, Germany). The splint and dress-
ing were maintained in place throughout the entire course of the 
experiment by the use of a jacket (Figure 2 B) made from adhesive 
tape (Leukoplast surgical tape, BSN Medical).
Debridement of the ulcer and assessment of contamination. 
Four days after wounding, the semiocclusive dressing was re-
moved, and a scab, defined as a crust of dried blood, serum, and 
exudate,54 was noted over each wound. By using strict aseptic 
Decontamination protocols. All surgical procedures were per-
formed in a sanitized surgery room by using autoclave-sterilized 
instruments. Because the procedures were repeated in multiple 
rats, 2 sets of instruments were used. Between uses, instruments 
were cleaned thoroughly to remove all organic debris, disinfected 
with a multipurpose disinfectant (Virkon, Antec International 
Limited, Suffolk, UK), and resterilized by using a glass bead ster-
ilizer (FST 250, Fine Science Tools, North Vancouver, Canada) 
according to the manufacturer’s guidelines. The surgeon wore 
clean scrubs, mask, and hair cap and used fresh sterile gloves for 
each rat.
Wounding, splinting, and dressing. The anesthetized rats were 
separated into 3 groups depending on the method of decontami-
nation of the dorsal skin: thorough washing with sterile saline 
only; thorough washing with sterile saline followed by disinfec-
tion with 10% povidone–iodine; and sterile saline plus povidone–
iodine (10 min contact time) followed by 70% isopropyl alcohol. 
A punch biopsy instrument (diameter, 6 mm; Accu-Punch, Acud-
erm, Fort Lauderdale, USA) then was used to create a full-thick-
Figure 2. Illustration of specific techniques. (A) The oval-shaped silicone splint and its dimensions. (B) Application of a jacket made from adhesive 
tape to prevent dressing loss. (C) Bacterial inoculation of the wound bed by inserting a 27-gauge, 19-mm needle attached to a 1-mL disposable syringe 
through the silicon splint at a 45° angle. (D) Wounds photographed from a standard 1.5 cm height by using a mounted digital microscope.
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viously described, and tissue samples were homogenized in 5 mL 
sterile saline in a pearl jar, vortexed for 20 s, and sonicated for 90 
s at 35 MHz (Transsonic T570, Elma, Singen, Germany) to disag-
gregate bacteria (this procedure had been optimized previously 
to minimize cell disruption). A 100-µL volume of the homogenate 
was used for the serial dilutions. Quantification was performed 
by using the 10-fold serial dilution method;28 100 µL of each dilu-
tion (either swab or tissue) was inoculated onto selective media 
(Chapman mannitol salt agar [Biokar Diagnostics] for Staphylococ-
cus aureus or cetrimide agar [Merck Chemical] for Pseudomonas 
aeruginosa). The plates were incubated under aerobic conditions 
at 37 °C for 24 h, after which colony counts were performed. The 
isolates grown on Chapman mannitol salt agar were presump-
tively identified as S. aureus based on colony morphology and 
mannitol salt agar fermentation.9 The isolates grown on cetrimide 
agar were presumptively identified as P. aeruginosa based on col-
ony morphology.7 Quantitative results are presented as the mean 
and standard deviation and expressed as logarithm-transformed 
values (log[cfu/swab] for swab samples and log[cfu/ulcer] for 
tissue samples). The data were compared by using a logarithmic 
scale owing to the wide variations in number of colony-forming 
units between cultures. Correlations were evaluated by the Pearson 
correlation coefficient, and the Fisher r-to-z method was used 
to calculate P values. A P value of less than 0.05 was considered 
significant. All data was entered into a spreadsheet program (Ex-
cel, Microsoft, Redmond, WA) for statistical analysis. Analytical 
statistics were performed by Analyse-it version 2.21 Excel 12+ 
(Analyse-it Software, Leeds, UK), a statistical add-in program for 
the spreadsheet program.
Optimized final rodent wound-infection model. General proto-
col and wound-closure kinetics. After every step of the procedure 
had been optimized, a final study (Figure 3) was designed by 
using 36 Wistar rats with chemically induced DM that were epi-
lated by using cold-wax strips. Incisions were made, splinted, and 
dressed as previously described. Wounds were photographed 
from a 1.5-cm standard height by using a mounted digital mi-
croscope (SuperEyes 200× USB Digital Microscope, Shenzhen 
Tak and Assistive Technology, Shenzhen, China; Figure 2 D), and 
the rats were divided randomly into 3 groups: inoculated with S. 
aureus (n = 12), inoculated with P. aeruginosa (n = 12), and negative 
control (n = 12). The ulcers of the animals in the infected groups 
were inoculated with either S. aureus or P. aeruginosa as previ-
ously described, whereas the ulcers of the negative control group 
were inoculated with sterile saline. On day 4 after wounding, 
the semiocclusive dressing was removed, the ulcer debrided and 
photographed, and a swab was obtained as previously described. 
The entire procedure, including debridement, was repeated on 
days 5, 8, and 11, and the splint chamber was filled twice daily 
with sterile saline from day 5 until the end of the study. Wound 
kinetics were quantified by using image-processing software (Im-
ageJ, US National Institutes of Health, Bethesda, MD) to measure 
the wound area by planimetry; wound area was expressed as 
a percentage of the initial wound area. Results are expressed as 
the mean of the percentage in area of the original wound size. 
Comparisons between groups were performed by using 2-tailed 
Student t tests, and a P value of less than 0.01 was considered 
significant. All data were entered into the spreadsheet program, 
and analytical statistics were performed as described previously.
Histologic analysis. For each group, 6 rats each were eutha-
nized by intraperitoneal injection of pentobarbital (200 mg) on 
technique, the ulcer was debrided by simple mechanical removal 
of the scab. The ulcer then was photographed as previously de-
scribed, and a liquid Amies elution swab (eSwab Collection and 
Preservation System, Copan, Corona, CA) was used to collect and 
transport swab cultures. Bacteria collection was performed by 
using the one-point method.45 Briefly, by using the sterile swab, 
the center surface of each wound was scrubbed carefully by ro-
tating the swab 3 times clockwise with enough manual pressure 
to produce a small amount of exudate. The inoculated swab was 
inserted into a tube containing 1 mL liquid Amies transport me-
dium and transported to the laboratory for immediate processing. 
The swab collection tube was vortexed (with the swab inside) for 
5 s, and a 100-µL aliquot of the suspension was used for serial 
dilutions. Quantification of the viable bacteria present in the swab 
was performed by using the 10-fold serial dilution method,28 and 
100 µL of each dilution was plated onto tryptone soy agar (Biokar 
Diagnostics, Pantin Cedex, France). The plates were incubated 
under aerobic conditions at 37 °C for 24 h, after which colony-
forming units were counted. The wound and surrounding area 
again were covered with a previously tailored, semiocclusive, 
nonwoven polyester dressing. Because all of these procedures are 
considered to be painless and noninvasive, they were performed 
on unanesthetized rats. A surgical drape was placed over the 
head of the rat to reduce stress and ensure immobilization. The 
entire procedure (including debridement) was repeated on days 
5, 8, and 11. Rats were evaluated twice daily for the integrity of 
the adhesive jacket, which was reinforced whenever deemed nec-
essary. On day 11, the rats were euthanized by intraperitoneal 
injection of pentobarbital (200 mg). Quantitative microbiologic 
results were expressed as the number of colony-forming units 
per swab and, on the basis of previous studies33 and the results of 
optimization study 3, rats with more than 103 cfu/swab on any 
given day were considered to be critically colonized. Results are 
presented as unit values and percentages.
Optimization study 3: assessment of wound bioburden. For this 
experiment, 14 Wistar rats with chemically induced DM were 
epilated by using cold wax, and an incision was made in each 
rat, splinted, and dressed as previously optimized and described. 
These ulcers were inoculated with bacterial suspensions of either 
Staphylococcus aureus or Pseudomonas aeruginosa. Clinical strains 
of S. aureus and P. aeruginosa that previously had been isolated 
from patients with chronic skin ulcers and cryopreserved at −70 
°C were grown on tryptone soy agar. After 24 h, bacterial cultures 
were harvested, and a bacterial suspension was prepared and 
compared with a McFarland standard (bioMérieux, Craponne, 
France). The inoculation dose was approximately 2.0 × 107 cfu/
mL. The rats were divided into 2 groups of 7 animals each (S. au-
reus and P. aeruginosa). After application of the dressing and with 
the rat still anesthetized, the wound bed was inoculated with 100 
µL of cultured bacteria (approximately 2.0 × 106 cfu) resuspended 
in sterile saline by inserting a 27-gauge, 19-mm needle attached 
to a 1-mL disposable syringe through the silicon splint at a 45° 
angle (Figure 2 C).
At 4 d after wounding, rats were euthanized by intraperitoneal 
injection of pentobarbital (200 mg), the semiocclusive dressing 
was removed, the ulcer was debrided, and a swab was obtained 
as described previously. Then, by using sterile surgical scissors, 
each wound was harvested in its entirety and placed in a sterile 
tube. Swabs and tissue samples were transported to the labora-
tory for immediate processing. The swabs were processed as pre-
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the anterioposterior axis and perpendicular to the surface of the 
wound. For each wound, 2 serial sections were placed on a slide 
and stained with hematoxylin and eosin. Under light microscopy, 
the sections were photographed by using an upright bright- 
field microscope equipped with a color camera (model DM2500, 
Leica Microsystems, Wetzlar, Germany) at 50× magnification. 
days 9 and 11, and each ulcer (including a 0.5-cm skin border) 
was harvested in its entirety by using sterile surgical scissors and 
placed in a tube. The sample was fixed overnight in 10% buffered 
formalin solution, after which the tissue was trimmed and cut 
through at the widest margin, embedded in paraffin, and sec-
tioned in 3-µm increments. Sections were made perpendicular to 
Figure 3. Final study design: optimized rodent wound infection model. Wistar rats each received a single intraperitoneal injection of streptozotocin; 8 
d after injection, rats considered to be diabetic (fasting blood glucose greater than or equal to 250 mg/dL) were epilated by using cold-wax strips. At 
4 d after epilation (study day 1), skin was disinfected, wounded, splinted, and photographed from a standard height. In addition, rats were divided 
randomly into 2 infected groups (inoculated with either Staphylococcus aureus or Pseudomonas aeruginosa) and 1 negative control group (inoculated with 
sterile saline). On study days 4, 5, 8, and 11, ulcers were (1) debrided, (2) swabbed, and (3) photographed. From day 5 until the end of the study, splint 
chambers were filled twice daily with sterile saline. On study days 9 and 11, half of the animals in each group were (4) euthanized, and each ulcer was 
processed for histologic analysis.
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val, 0.065 to 0.966; P = 0.037) for P. aeruginosa, suggesting a strong 
relationship between the 2 independent measures. This statistical 
correlation was not observed when data from the 2 infected 
groups were combined.
Optimized rodent wound-infection model. Wound-closure 
kinetics. In the final wound-infection model study, the control 
group showed continuous reduction of the wound area that was 
enhanced after mechanical debridement (Figure 5).[ID]FIG5[/ID] During the 
first 4 d after infection, the wound area increased on average to 
110.6% of the original size in the P. aeruginosa group and 102.3% 
of the original size in the S. aureus group. After the first debride-
ment, the wound area began to decrease, paralleling a decrease in 
the microbial load. There was a statistically significant difference 
(P < 0.01) in wound area between the negative control and both 
infected groups on days 8 and 9; on day 11, only the difference 
between the negative control and Pseudomonas aeruginosa groups 
remained significant. Microbial load was similar between the 2 
infected groups (5.66 compared with 5.54 log[CFU/swab]) on day 
4 and did not differ significantly on days 5, 8, and 11.
Histologic analysis. Both EG and DG decreased (P < 0.01) as the 
GT area increased in all groups from day 9 to day 11 (Figure 6).[ID]FIG6[/ID] 
On day 9, EG closure was significantly delayed in infected groups 
compared with controls (S. aureus, 0.12 ± 0.06 mm; P. aeruginosa, 
1.3 ± 0.15 mm; control, 1.55 ± 0.15 mm; P < 0.01). By day 11, all 
wounds were completely reepithelialized, except for a single ul-
cer in the rats inoculated with P aeruginosa. GT area did not dif-
fer between groups on either day 9 or 11. However, DG closure 
followed wound contraction, as evaluated by digital planimetry. 
Wounds of infected rats showed significantly less DG closure 
than did those of control rats on days 9 (S. aureus, 1.88 ± 0.09 mm; 
P. aeruginosa, 2.93 ± 0.08 mm; control, 3.17 ± 0.15 mm; P < 0.01) and 
11 (S. aureus, 1.30 ± 0.16 mm; P. aeruginosa, 2.20 ± 0.15 mm; control, 
2.43 ± 0.06 mm; P < 0.01). DG closure did not differ significantly 
between infected groups.
Discussion
The impairment of wound healing by DM, which is potenti-
ated by infection, causes a significant amount of human morbidity 
and mortality worldwide14,30 and has prompted the investigation 
of new TAT approaches. Although swine are thought to be the 
ideal large animal model for cutaneous disease,18 the use of ro-
dents overcomes several of its disadvantages (for example, size, 
cost, housing, husbandry, and reagent validation). Therefore, ro-
dents are still the model of choice for research purposes in this 
area. However, there are no standardized wound-infection models 
for testing TAT.
One well-known rodent model16 is a splinted, excisional 
wound-healing model that involves genetically diabetic mice 
(db/db mice). In contrast, we used male Wistar rats in which DM 
Panoramic cross-sectional digital images of each wound were pre-
pared by using professional image-editing software (Photoshop 
CS2, Adobe Systems, San Jose, CA). The images were analyzed 
for epithelial gap (EG), dermal gap (DG), and total granulation 
tissue (GT) area by using image-processing software. EG was 
defined as the distance between the advancing edges of clear, 
multiple-layer neoepidermis,16,36 and its size was measured in 
millimeters, with an EG of 0 representing a completely reepitheli-
alized wound. DG was defined as the distance between uninjured 
dermis on both sides of the wound16,36 and was measured in mil-
limeters. GT area was calculated by computerized morphometric 
analysis16 and expressed in square millimeters. The results are 
presented as mean ± SEM. Comparisons between groups were 
performed by using 2-tailed Student t tests, and a P value of less 
than 0.05 was considered significant. All data were entered into 
the spreadsheet program and analytical statistics were performed 
as described previously.
Results
Animals and induction of DM. We induced diabetes in 98 male 
Wistar rats with a success rate of 81.6%. Of the 80 successfully 
induced rats, 3.8% died prior to the end of the study; at necropsy, 
no significant gross pathology was noted. There was no mortality 
during the optimized final study. For the final study, 77 animals 
(78.6% of the number of rats induced initially) were used. At the 
time of euthanasia, all rats were confirmed to have fasting glu-
cose levels of at least 250 mg/dL, and the mean weight loss was 
18.10% ± 2.35%.
Optimization study 1: hair removal. Depilation by using a 
straight razor gave the worst hair density and skin damage re-
sults throughout the 15 d of the experiment (Figure 4). Although 
cold wax tended to cause increased immediate (day 1) epithelial 
injury, as measured by the skin-damage index, compared with 
that from the depilatory cream, this pattern was completely 
reversed by day 4. Epilatory hair removal by using cold wax 
achieved more prolonged results than did the depilatory meth-
ods (straight razor or depilatory cream), as evaluated by using the 
hair-density index, with less skin damage after day 4, which was 
the optimal day for infection.
Optimization study 2: prevention of unintentional critical colo-
nization. This experiment examined methods for preventing un-
intentional critical bacterial colonization. The use of a combined 
approach (washing with sterile saline, followed by disinfection 
with povidone–iodine and washing with isopropyl alcohol af-
ter 10 min contact time) produced the best results (Table 1), with 
only 1 of the 6 control wounds having a swab colony count that 
exceeded 3 logs (4.6 × 105 cfu/swab). No dressing or splint was 
lost during the experiment.
Optimization study 3: assessment of wound bioburden. The 
average colony count in swab samples (Table 2) was similar be-
tween the 2 species: 5.67 ± 0.16 log(cfu/swab) for S. aureus and 
5.65 ± 0.26 log(cfu/swab) for P. aeruginosa. The colony counts in 
tissue samples differed between the 2 species by 0.16 log(cfu/
ulcer) but this difference was not statistically significant (2-tailed 
t test, data not shown). The one-point quantitative swab method 
underestimated the number of bacteria in the wound bed by 1.79 
± 0.10 log(cfu) for S. aureus and 1.97 ± 0.16 log(cfu) for P. aerugi-
nosa. The Pearson correlation coefficient (r) between swab and 
tissue colony counts was 0.810 (95% confidence interval, 0.143 
to 0.971; P = 0.025) for S. aureus and 0.780 (95% confidence inter-







lowed by 10 min 
of 10% povidone–
iodine (n = 6)
Sterile saline, 10 min of 
10% povidone-iodine, 
and 70% isopropanol 
(n = 6)
≤103 2 (33.3%) 3 (50.0%) 5 (83.3%)
>103 4 (66.7%) 3 (50.0%) 1 (16.7%)
aBacterial count >103 cfu/swab on any given study day
cm11000097.indd   42 1/27/2012   2:47:49 PM
Rat model of diabetic wound infection
43
for inhalant anesthesia before procedures and reducing the associ-
ated time, distress, and mortality risks. Except for during the initial 
epilation and wounding procedures, the rats in our current study 
were restrained simply by placing a surgical drape over the rat’s 
head to maintain immobilization in the absence of any identifi-
able behavioral stress signs.
We have used streptozotocin-induced diabetic Wistar rats rath-
er than one of the available rat genetic models. Although genetic 
models offer some undisputed advantages, they are of limited 
availability and are expensive for regular screening studies of 
wound healing related to DM.41 Further, the most common and 
readily available of genetically diabetic rats are obese to the point 
had been chemically induced as a rodent model. Rats are a widely 
used biomedical research animal and currently the primary mod-
el for many preclinical tests, including those in the DM field.22 
Although the use of rat models has declined in the last decade, 
mainly due to broad advances in the development of mouse ge-
netic technologies, rats still afford many advantages over mice, 
primarily in regard to size and behavioral characteristics.20 In our 
case, the adhesive-tape jacket needed to prevent dressing loss and 
subsequent unintentional critical colonization would be impos-
sible to adapt to a smaller rodent. Moreover, we expected our 
studies to involve frequent, nonpainful procedures. Rats often 
are easier to train and handle than are mice,34 obviating the need 
Figure 4. Results of the hair-removal optimization study. After dorsal hair trimming, rats were divided into 3 groups: straight razor, depilatory cream, 
and cold wax. Photographs were taken immediately, 4 d, and 14 d after removal procedures; 3 independent observers evaluated 2 parameters: hair-
density index (HDI) and skin-damage index (SDI). Results are expressed as median (first and third quartiles).
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failure of skin contraction restriction and consequent exclusion 
of animals from the study.53 This problem is particularly impor-
tant in wound infection models, because razor shaving produc-
es microscopic cuts in the epidermis, and hair growth around 
the wound site acts as a wick, both of which increase the risk of 
wound contamination. Cold waxing, as indicated by the hair-
density index we used here, was more effective than were shav-
ing or chemical depilatories because waxing removed the hair 
from beneath the skin surface.2 This improvement in limiting hair 
growth was made at the expense of persistent skin lesions. How-
ever, although cold wax tended to cause more immediate (day 
1) epithelial injury, as measured by the skin-damage index, than 
did depilatory cream, this effect was completely reversed by day 
4. This outcome is consistent with previous skin electrical poten-
tial studies,2 which showed that waxing causes stratum corneum 
damage with an immediate loss of cutaneous barrier function and 
has a rapid and apparently complete recovery by the fifth day 
after treatment. From our optimization study and based on the 
previously cited skin electrical potential study,2 we decided to use 
cold waxing epilation in our final study at 4 d before wounding. 
This strategy prevented regrowth of hair throughout the course of 
the experiment and maintained the barrier function of the healthy 
surrounding skin.
The conversion of an excisional wound model to a wound-in-
fection model is simple enough. The addition of a known concen-
tration of virulent bacteria to the wound bed establishes infection 
in the test group,18 but the most difficult problem to solve is the 
prevention of unintentional critical colonization or infection. Al-
though sterilization of the wound is impossible, the use of strict 
measures can prevent colonization by pathogenic or normal skin 
flora microorganisms beyond a certain threshold, above which 
there may be impairment to wound healing. We and others5,33 
consider this limit to be a tissue microbial load of 105 cfu/g tis-
sue or 103 cfu/swab. A bioburden below this threshold does not 
seem to impair tissue repair and frequently has a positive effect 
on wound healing.23 One potential criticism of our current study 
is that we did not include a chlorhexidine-based antiseptic solu-
tion test group; this type of antiseptic is considered to be ideal 
for wound infection prevention because of its persistent activ-
ity that prevents regrowth of microorganisms for at least 24 h.27 
This characteristic was the reason we did not include this type 
of disinfectant in our model: we would have had to pretreat the 
infection test group with the antiseptic solution, and its residual 
antiseptic activity might have limited the development of infec-
tion. We chose to use 10% povidone–iodine and 70% isopropyl al-
cohol, because these agents have an immediate bactericidal action 
but minimal residual activity.26 This strategy has been adopted in 
another animal model of diabetic wound infection.19
that excisional wound closure is impeded not only by physiologic 
dysfunction but also by excess subcutaneous fat.11
Streptozotocin targets and inhibits pancreatic β-cell function 
without affecting the exocrine function and produces a DM type 
1 phenotype with residual insulin secretion that enables animals 
to live longer than do genetic models before insulin treatment 
is needed. However, in addition to this biochemical deficit, this 
chemical agent causes other effects, such as altered T cell function 
and decreased macrophage phagocytosis, which also may con-
tribute to impaired healing.17,36,38 Nevertheless, the streptozotocin 
model is one of the most suitable for use in wound healing stud-
ies, allowing accurate quantification of the main aspects of a heal-
ing wound such as wound closure, reepithelialization, and GT 
formation. In addition, we used male rats, whose pancreatic islet 
β cells are more prone to streptozotocin-induced cytotoxicity than 
are those of female rats52 and which have 40% stronger skin than 
do female rats, due to a much thicker dermis.51 Our DM-induction 
rate exceeded 80%, as expected for the protocol,52 and the postin-
duction mortality rate was low (less than 5%).
The silicone splint was used in previous models because it 
minimized wound contraction without affecting the rate of reepi-
thelialization, thus better recapitulating the repair mechanisms 
underlying human wound healing.51 In our current study, the 
splint had the additional benefit of creating a sealed artificial 
chamber over the wound, maintaining sterility at the wound site 
and allowing the establishment of a monoculture infection while 
enabling the application of products in a liquid vehicle. We filled 
this chamber twice daily with sterile saline, which provided a wet 
wound microenvironment beneficial to wound healing.49 Ster-
ile saline is also the most frequently used negative TAT control. 
The influence of the splint and dressing maintenance on wound 
closure has been reported as a problem.16,36 When the dressing is 
breached, the wound becomes contaminated, and splint loss is 
easier. Once animals lose the splint, wound closure occurs more 
rapidly. All of these factors can lead to the exclusion of animals 
from the study; therefore, meticulous application and mainte-
nance of the dressing that protects the splint is an essential aspect 
of model standardization. To prevent dressing loss, we intro-
duced a jacket made from adhesive tape. With twice-daily evalu-
ation for the integrity of the adhesive-tape jacket and the addition 
of reinforcement whenever deemed necessary, we had a 100% 
success rate of maintaining the dressing and splint to the end of 
the experiment. The jacket seemed to be well tolerated by the rats, 
which exhibited no overt signs of distress.
Rodent skin is covered with dense hair that undergoes a 
defined cycle of hair growth similar to that of human hair.11 
Although hair removal protocols are described in detail only in-
frequently in studies, hair regrowth has been reported as an im-
pediment to splint and dressing skin adherence, resulting in the 
Table 2. Bacterial colony counts (log[CFU]) from tissue or swab culture of wounds infected with Staphylococcus aureus or Pseudomonas aeruginosa
log(cfu) (mean ± 1 SD)
Pa (95% confidence interval)Tissue Swab Tissue – swab Pearson R
S. aureus (n = 7) 7.46 ± 0.17 5.67 ± 0.16 1.79 ± 0.10 0.810 0.025 (0.143–0.971)
P. aeruginosa (n = 7) 7.62 ± 0.18 5.65 ± 0.26 1.97 ± 0.16 0.780 0.037 (0.065–0.966)
Overall (n = 14) 7.54 ± 0.19 5.66 ± 0.21 1.88 ± 0.16 0.743 nonsignificant
aP value as calculated by the Fisher r-to-z method
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Figure 5. Results of the final wound-infection model study. The line graph illustrates wound healing kinetics of the infected (Staphylococcus aureus or 
Pseudomonas aeruginosa) and negative control groups. Each point represents the mean of the percentage in area of the original wound size. After day 
4, wound area decreased progressively and was enhanced after mechanical debridement. Wound area differed significantly (*, P < 0.01) between the 
negative control and both infected groups on days 8 and 9 and between the negative control and Pseudomonas aeruginosa-inoculated groups on day 11. 
The bar graph illustrate microbial load (from quantitative swab-sample cultures and expressed in no. of cfu per swab [log scale]) between the 2 infected 
groups on days 4, 5, 8, and 11. The Staphylococcus aureus-inoculated group showed a trend (0.05 < P < 0.10) toward increased microbial load on days 5, 
8, and 11. The lower panel contains macrophotographs of wounds from a representative rat in each group at each time point.
One of the greatest controversies in wound management is the 
usefulness of quantitative swab cultures for predicting the pres-
ence of wound infection. This method has received criticism be-
cause it is thought to estimate wound-surface microbial numbers 
only and not deep-tissue numbers.5 However, several studies in 
humans and animals have demonstrated high sensitivity (93.5% 
to 100%) and good specificity (76.3% to 94.2%) and accuracy (ap-
proximately 90% to 99%) when compared with tissue-biopsy 
quantitative cultures.44,45 In an experimental acute-wound rat 
model, a tissue count of 105 cfu/g was equivalent to a count of 
103 cfu/mL obtained from a moist swab; 4 another study45 dem-
onstrated that compared with biopsy cultures, one-point quan-
titative swab cultures detected similar types of microorganisms 
but underestimated bacterial numbers by a factor of 2 logs. These 
studies suggest that the quantitative swab method of collection 
and culturing is acceptable, given its correlation with the invasive 
method. The invasive method was strongly contraindicated in the 
model we developed because our study required serial evalua-
tions of the bioburden, along with planimetry by digital photog-
raphy and a final histologic evaluation. Because these measures 
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periwound flora. In a murine DM wound-healing model using 
quantitative cultures and transmission electron microscopy stud-
ies,54 the majority of bacteria were in the scab above the wound 
bed rather than in the wound tissue. In addition, ulcer debride-
ment (that is, the removal of the scab), which is essential to the 
model we developed, reproduced the current clinical practice of 
wound debridement previous to microbiologic sampling5 and 
theoretically provided an improved estimate of deep-tissue bac-
terial numbers. Although the numbers of colonies obtained from 
constituted the final endpoints and would have been influenced 
by the wound-bed trauma induced by serial biopsies, we opted 
for swabbing.
Many methods3 have been described for swab collection 
(10-point diagonal method, 1-cm2-area sampling method, and 
one-point rotation method), but none has gained universal 
acceptance. In the current study and in accordance with oth-
ers,45 we selected the one-point method because of the relatively 
small size of the wounds and to better avoid contamination with 
Figure 6. Quantitative histologic evaluation of epithelial gap (EG), dermal gap (DG), and granulation tissue (GT) area in the negative control and both 
infected (Staphylococcus aureus or Pseudomonas aeruginosa) groups on days 9 and 11. On day 9, EG closure in both infected groups was significantly (*, 
P < 0.01) delayed compared with that in the control group. On days 9 and 11, wounds in the infected groups showed significantly (*, P < 0.01) less DG 
closure than did the control group. Original magnification, ×50.
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swab and tissue samples varied, both samples were correlated 
logarithmically for each bacterium. Our data indicated that the 
one-point swab culture yielded an average 1.9 log(cfu) under-
estimation of colony counts compared with those of the tissue 
cultures, consistent with the results of several other clinical and 
experimental studies.4,29,45 Surprisingly, we found that when P. ae-
ruginosa and S. aureus groups were pooled before evaluation, this 
correlation could not be reestablished. Our results, which show 
underestimation of P. aeruginosa swab samples relative to S. aureus 
swab samples, may be explained by differential distribution of 
the 2 bacteria in the wound. This notion is in line with a previous 
study,15 in which confocal laser scanning microscopy of clinical 
wound-biopsy specimens demonstrated that the distance from P. 
aeruginosa aggregates to the wound surface was greater than that 
of S. aureus aggregates, leading to underestimation of P. aeruginosa 
in swab samples. This result supports the possibility that factors 
intrinsic to each pathogenic bacteria contribute, as does sampling 
technique, to the differences reported in studies comparing swab 
and tissue-sample quantitative cultures. Finally, the choice of se-
lective media (cetrimide or Chapman mannitol salt agar) is im-
portant, because using the proper medium is essential for the 
correct evaluation of target pathogens5 and to prevent concurrent 
colonization by other microorganisms. The noninvasiveness of 
the quantitative swab, which allowed concomitant debridement 
and revealed a strong correlation with tissue sampling, made this 
method ideal for use in our rodent wound-infection model.
After optimizing each step of the process, we designed a proto-
col allowing the simultaneous and serial assessment of microbial 
load (by using quantitative swab-sample cultures) and the ki-
netics of wound closure (through digital photography and com-
puterized planimetry software) and a well-defined and easily 
repeatable quantitative histologic evaluation. It was our require-
ment that the model not only accurately paralleled the healing of 
infected wounds in humans but also the current treatment stan-
dard of care. Sharp debridement is standard procedure in wound 
management, and there is no clinical or experimental rationale 
for using TAT products in its absence.25 Debridement converts 
the molecular and cellular environment of a chronic wound to 
that of an acute, healing wound through the removal of scabs and 
debris. Many studies37,50,54 indicate that debridement plays an im-
portant role in removing bioburden and enhancing cicatrization, 
and its frequency is directly related to the rate of healing.43 Fur-
thermore and most importantly, debridement has been shown in 
several models to open a time-dependent window for TAT use.50 
Debridement led to a significant decrease in the resistance of the 
bioburden to TAT for as long as 24 h, with resistance increasing to 
reach the original resistance levels at 72 h.
Our current study using a rat model replicates the current de-
bridement protocol for infected diabetic ulcers.42 Initial debride-
ment (day 4) removed a cellular burden of dead and senescent 
cells and excessive bacterial load; additional maintenance debri-
dement (days 5 and 8) maintained the wound environment and 
the readiness of the wound bed for healing. The effects of debri-
dement are manifest in our model: first, by limiting the increase 
in the size of the wound area after day 4, and second, by accel-
erating wound-healing kinetics as revealed by the inflections in 
the infected-wound healing curve, which becomes parallel to the 
control curve from the third debridement onwards. In the current 
study, macroscopic wound closure showed a similar trend when 
compared with that of the EG and DG measured in histologic 
specimens among the control and infected groups. There was not, 
however, a statistically significant difference in GT area among 
groups. This result is probably related to an increase in collag-
enolytic activity in the wound, generating increased feedback 
synthesis.8 Qualitative differences in GT between groups may 
exist, and additional studies, such as complementary breaking-
strength measurements, would be of interest. From the analysis 
of the planimetry and histologic data, we can conclude that in 
our model, the best time to evaluate differences between the in-
fected and control groups is day 9, and TAT studies probably will 
not benefit from a longer period of evaluation. In addition, DG 
closure is a better parameter than is GT area for evaluating the 
histologic level of contraction of the wound.
In summary, we optimized a new wound infection model in 
chemically induced diabetic Wistar rats. This model can be used 
to investigate new approaches to TAT. The model has numerous 
benefits: the necessary materials and techniques are simple, re-
producible, and practical for experiments with large sample sizes. 
Furthermore, in light of the analogies to human-infected wound 
healing and treatment, this model can serve as a valid alternative 
for applied research.
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